The role of c-Met and VEGFR2 in glioblastoma resistance to bevacizumab

Dismal prognosis of glioblastoma (GBM) prompts for the identification of response predictors and therapeutic resistance mechanisms of current therapies. The authors investigated the impact of c-Met, HGF, VEGFR2 expression and microvessel density (MVD) in GBM patients submitted to second-line chemoth...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Rep
Hlavní autoři: Carvalho, Bruno, Lopes, José Manuel, Silva, Roberto, Peixoto, Joana, Leitão, Dina, Soares, Paula, Fernandes, Ana Catarina, Linhares, Paulo, Vaz, Rui, Lima, Jorge
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7966794/
https://ncbi.nlm.nih.gov/pubmed/33727583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-85385-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky